International Journal of Surgical Pathology · 2004 · 41 citations · 22 references
Veterinary MedicineOncologyPathologyMetastasisNeoplasiaTumor PathologyMalignant NeoplasmsMalignant TumorsMelanocytic TumorsNeoplastic PathologySkin TumorsTumor ClassificationImmunohistochemical BiomarkersImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical StainingMelanoma HistopathologySpindle Cell MelanomaSpindle Cell TumorsTumor Thickness Prognosis
Studies of the immunohistochemical profiles and clinical course of desmoplastic melanoma have produced conflicting results. We identified 28 cases of desmoplastic melanoma after a search of our files for spindle cell neoplasms of the head and neck from 1960 through 1995. The 17 male (61%) and 11 female (39%) patients averaged 65 years of age. The cheek was the most common location (12 cases, 43%). The average length of follow-up was 5 years. Overall 5-year survival rate was 46%. Melan A and tyrosinase positivity (P = 0.0195), smooth muscle actin positivity (P = 0.0328), tumor size (P = 0.0297), and tumor thickness (P = 0.0419) were significantly associated with local progression-free survival. No histologic or immunohistochemical marker was associated with overall or metastasis-free survival.
22
Desmoplastic malignant melanoma (A rare variant of spindle cell melanoma)
John Conlev, Raffaele Lattes, William Orr · Cancer · 1971 · 368 citations · Full text
Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases
J. Andrew Carlson, G. Richard Dickersin, Arthur J. Sober et al. · Cancer · 1995 · 280 citations
Desmoplastic and desmoplastic neurotropic melanoma
Michael J. Quinn, Kerry A. Crotty, John F. Thompson et al. · Cancer · 1998 · 264 citations
Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients.
Michael J. Quinn, Kerry A. Crotty, John F. Thompson et al. · PubMed · 1998 · 257 citations
Richard J. Reed, Donald D. Leonard · The American Journal of Surgical Pathology · 1979 · 247 citations